Business Context and Reporting Period
Company: American Shared Hospital Services
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 1999
Business Overview: The Company primarily provides Gamma Knife units to medical centers. In November 1998, it sold its diagnostic imaging and respiratory therapy services (CuraCare, Inc.) to a third party. As of June 30, 1999, the Company operates six Gamma Knife units.
Key Financial Metrics
| Metric | Three Months Ended June 30, 1999 | Six Months Ended June 30, 1999 | Dec 31, 1998 (Balance Sheet) |
|---|---|---|---|
| Revenues (Medical Services) | $1,712,000 | $3,278,000 | N/A |
| Net Income | $495,000 | $983,000 | N/A |
| Earnings Per Share (Basic) | $0.13 | $0.24 | N/A |
| Gross Margin % | 72% | N/A | N/A |
| Cash and Cash Equivalents | N/A | N/A | $10,430,000 |
| Restricted Cash | N/A | N/A | $50,000 |
| Total Assets | N/A | N/A | $28,834,000 |
| Total Liabilities | N/A | N/A | $17,724,000 |
| Shareholders' Equity | N/A | N/A | $11,110,000 |
| Working Capital | N/A | N/A | $8,793,000 |
Material Changes vs. Prior Period
- Revenue Decline: Medical services revenues decreased $8.1 million (Q2) and $15.9 million (YTD) compared to the prior year, primarily due to the November 1998 sale of diagnostic imaging services. However, Gamma Knife revenues increased by $903,000 (Q2) and $1.8 million (YTD) due to higher utilization and new units.
- Cost Reductions: Total costs of operations decreased significantly ($6.8 million Q2; $13.3 million YTD) driven by the sale of the imaging division and the elimination of payroll and equipment rental costs associated with that segment.
- Profitability Improvement: Net income increased to $495,000 (Q2) and $983,000 (YTD) from $300,000 and $505,000 in the prior year periods. Gross margin improved to 72% in Q2 1999 from 26% in Q2 1998.
- Cash Flow: Net cash provided by operating activities was $1.7 million for the six months ended June 30, 1999, compared to $6.5 million in the prior year. The decrease is attributed to lower receivables and higher payments for taxes and exit costs related to the sale.
Guidance, Outlook, and Risks
- Outlook: Management believes current cash and working capital are adequate to service 1999 requirements. The Company is investing cash in overnight repurchase agreements and commercial paper.
- Contract Negotiations: The contract for the second Gamma Knife unit terminates in Q3 1999. The Company is negotiating to sell the unit, extend the contract, or remove it.
- Year 2000 (Y2K) Risk: The Company is upgrading computer systems to be Y2K compliant, with completion expected in Q3 1999 at a cost not exceeding $80,000. Current Gamma Knife revenue sources are Y2K compliant. Material impact would only occur if customer disbursement systems fail to process payments on January 1, 2000.
- Share Repurchase: The Company repurchased $969,000 of its own stock during the six-month period.
Investor Verification Checklist
- Verify the status of negotiations regarding the Gamma Knife unit contract terminating in Q3 1999.
- Confirm the timeline and cost of Y2K compliance upgrades for internal systems and the Y2K status of customer disbursement systems.
- Review the utilization rates of the six operational Gamma Knife units to validate revenue growth projections.
- Monitor the Company's cash burn rate relative to the $10.4 million cash balance and upcoming debt obligations.
- Assess the impact of the minority interest (19% in GKF) on future net income distribution.